Oasmia Pharmaceuticals Chairman Anders Lönner Resigns

February 28, 2017

Uppsala, Sweden February 28, 2017 – Chairman Anders Lönner of Oasmia Pharmaceutical AB (NASDAQ: OASM) has has informed the Nomination Committee that he does not wish to be re-elected as Chairman and Member of the Board.
“My role as Chairman was not meant to be long-lasting. The Company needs a consistent, long-term executive Chairman to move its promising projects forward. After sharing several insights and suggestions for the direction of the Company, I resign from my active role on the Board of Directors, but will continue to be at the Company’s disposal moving forward as needed.

”Oasmia är skyldigt att offentliggöra informationen i detta pressmeddelande enligt lagen om handel med finansiella instrument. Informationen lämnades för offentliggörande den 28 Feb 2017 kl.22.15”